Joe Palca

Joe Palca is a science correspondent for NPR. Since joining NPR in 1992, Palca has covered a range of science topics — everything from biomedical research to astronomy. He is currently focused on the eponymous series, "Joe's Big Idea." Stories in the series explore the minds and motivations of scientists and inventors.

Palca began his journalism career in television in 1982, working as a health producer for the CBS affiliate in Washington, DC. In 1986, he left television for a seven-year stint as a print journalist, first as the Washington news editor for Nature, and then as a senior correspondent forScience Magazine.

In October 2009, Palca took a six-month leave from NPR to become science writer in residence at the Huntington Library and The Huntington Library, Art Collections, and Botanical Gardens.

Palca has won numerous awards, including the National Academies Communications Award, the Science-in-Society Award of the National Association of Science Writers, the American Chemical Society James T. Grady-James H. Stack Award for Interpreting Chemistry for the Public, the American Association for the Advancement of Science Journalism Prize, and the Victor Cohn Prize for Excellence in Medical Writing.

With Flora Lichtman, Palca is the co-author of Annoying: The Science of What Bugs Us (Wiley, 2011).

He comes to journalism from a science background, having received a Ph.D. in psychology from the University of California at Santa Cruz where he worked on human sleep physiology.

Transcript

TESS VIGELAND, HOST:

From the studios of NPR West in Culver City, California it's ALL THINGS CONSIDERED. I'M Tess Vigeland. Let us contemplate the American teenage girl, perhaps the very first one. Apparently, there's been some scientific debate about who she is and whether she hails from the same gene sequence as what we think of as the first Americans, American Indians. And when I say gene sequence, we're not talking about Skinnies from Urban Outfitters. NPR's science correspondent Joe Palca has the story of a very old American teenage identity crisis.

When Bryan and Elizabeth Shaw learned that their son Noah had a potentially deadly eye cancer, like a lot of people, they turned to their religious faith to help sustain them. But faith is also impelling Bryan Shaw to create software to detect eye cancer in children as soon after birth as possible.

A scientist's ambitious plan to create an early detection system for eye cancer using people's home cameras is coming along.

Removing all the dangerous bacteria from drinking water would have enormous health benefits for people around the world.

The technologies exist for doing that, but there's a problem: cost.

Now a scientist at the Massachusetts Institute of Technology thinks he's on to a much less expensive way to clean up water.

There's only one thing better than having a good idea, and that's having a good idea that really works.

Earlier this year, I reported on some students at Rice University who had designed a low-cost medical device to help premature infants breathe.

Transcript

DAVID GREENE, HOST:

Scientists may have filled in a gap in one the fundamental theories of physics. We've always been told that magnets have two poles, north and south. But theory suggests there should be something called a magnetic monopole, a magnet that has either a north pole or a south pole but not both of them. So far no one has found this elusive magnetic monopole.

Good ideas don't only come from experts. An innovative engineering program in Texas has been proving that college undergraduates can tackle — and solve — vexing health challenges in developing countries.

Two engineers at Rice University in Houston are tapping the potential of bright young minds to change the world.

Big Problems, Simple Solutions

Three engineering undergrads at Rice University gave a teenager with a rare genetic disease something he'd always wished for: the ability to turn off the light in his room.

It may not seem like much, but for 17-year-old Dee Faught, it represents a new kind of independence.

Bryan Shaw never expected to write a research paper about a rare eye cancer.

Pages